We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Factory Location: No.3 Jianye Avenue, High-Tech Zone, Leshan, Sichuan, China
Main Sales Markets: Central/South America,Eastern Europe,Australasia,Asia,Middle East,Africa
Packaging Information: 1g,10g,1kg, 5kg
Delivery Lead Time: 2 weeks
Sample Provided: no
Payment Terms: T/T
Tirzepatide, is a medication used for the treatment of type 2 diabetes.
Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are hormones involved in blood sugar control. After a person has eaten, these hormones are secreted by cells of the intestines and in turn cause the secretion of insulin. Tirzepatide is a GIP-analogue which activates both the GLP-1 and GIP receptors, leading to improved blood sugar control..
Tirzepatide is a glucose-dependent insulin-stimulating peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor dual agonist that integrates the two insulin-stimulating effects into a single molecule. Through a dual mechanism of action to activate the hormone receptors involved in blood glucose control -GIP and GLP-1 two incretin receptors.
Tirzepatide, is a medication used for the treatment of type 2 diabetes.
Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are hormones involved in blood sugar control. After a person has eaten, these hormones are secreted by cells of the intestines and in turn cause the secretion of insulin. Tirzepatide is a GIP-analogue which activates both the GLP-1 and GIP receptors, leading to improved blood sugar control..
Tirzepatide is a glucose-dependent insulin-stimulating peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor dual agonist that integrates the two insulin-stimulating effects into a single molecule. Through a dual mechanism of action to activate the hormone receptors involved in blood glucose control -GIP and GLP-1 two incretin receptors.
Three years of qualification
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
![Acetic acid, chloro[(4-methoxyphenyl)hydrazono]-, ethyl ester, (2Z)-](https://eimg.pharmasources.com/image/20211116/S6T5LYeCqEw1WTjpz2QY9CvhuTbaJ6vt6UfshAvH.jpeg!145)
